Semaglutide × Instant Peptides - Lab Test, March 2026
Test results
About this test
This independent RP-HPLC lab test confirms Semaglutide 30mg from Instant Peptides at 99.954% purity. The analysis was conducted by Kovera Labs on March 9, 2026, under report number KVR-2026-67A397.
The tested sample contained 33.36 mg of net peptide content, exceeding the stated label quantity of 30 mg. A purity level of 99.954% indicates exceptional synthesis quality with minimal impurities. Endotoxin safety screening confirmed Pass status at ≤0.5 EU/mL. Heavy metal screening detected negative results for lead, cadmium, arsenic, and mercury. Microbial sterility screening showed no growth. The product specification confirms appearance as a clear cap vial with silver crimp containing lyophilized powder with identity confirmed by LC-MS as Semaglutide.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.